Management of Advanced Prostate Cancer in the Precision Oncology Era

SIMPLE SUMMARY: This review article details new precision oncology-based therapeutics used to treat advanced prostate cancer. Metastatic castration-resistant prostate cancer remains an incurable diagnosis, however newly identified biomarkers have expanded treatment repertories for some patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Gillette, Claire M., Yette, Gabriel A., Cramer, Scott D., Graham, Laura S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177563/
https://www.ncbi.nlm.nih.gov/pubmed/37174018
http://dx.doi.org/10.3390/cancers15092552

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177563/
https://www.ncbi.nlm.nih.gov/pubmed/37174018
http://dx.doi.org/10.3390/cancers15092552

Ejemplares similares